Use of intravenous polymyxin B during continuous venovenous hemodialysis

J. C. Sarria, F. Angulo-Pernett, R. C. Kimbrough, C. S. McVay, A. M. Vidal

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Described here is the case of a 23-year-old male with Acinetobacter baumannii sepsis and acute renal failure requiring continuous venovenous hemodialysis treated successfully with intravenous polymyxin B. The drug was administered as a loading dose of 2.5 mg/kg, followed by 2 doses of 1 mg/kg on days 4 and 8, then 0.8 mg/kg daily to complete a 24-day course. A discussion of dosing recommendations for polymyxins in dialysis is presented.

Original languageEnglish (US)
Pages (from-to)340-341
Number of pages2
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume23
Issue number4
DOIs
StatePublished - Apr 2004
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Use of intravenous polymyxin B during continuous venovenous hemodialysis'. Together they form a unique fingerprint.

Cite this